Stage II Penile Cancer
Current Clinical Trials
Stage II penile cancer is defined by the following TNM classifications:
- T1, N1, M0
- T2, N0, M0
- T2, N1, M0
Standard treatment options:
- Stage II penile cancer is most frequently managed by penile amputation for
local control. Whether the amputation is partial, total, or radical will
depend on the extent and location of the neoplasm. External beam radiation therapy and brachytherapy with
surgical salvage are alternative approaches.[1-5]
Treatment options under clinical evaluation:
- Nd:YAG laser therapy has been used to preserve the penis in selected patients
with small lesions.[6]
Because of the high incidence of microscopic node metastases, elective
adjunctive dissection of clinically uninvolved (negative) lymph nodes in
conjunction with amputation is often used for patients with poorly
differentiated tumors. Lymphadenectomy, can carry substantial
morbidity, such as infection, skin necrosis, wound breakdown, chronic edema,
and even a low, but finite, mortality rate. The impact of prophylactic
lymphadenectomy on survival is not known.[7-10]
To reduce the morbidity associated with prophylactic lymphadenectomy, dynamic sentinel node biopsy is being used in patients with stage T2 clinically node-negative penile cancer. One retrospective single-institution study of 22 patients reported a false-negative rate of 11%.[11]
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage II penile cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
References
-
Harty JI, Catalona WJ: Carcinoma of the penis. In: Javadpour N, ed.: Principles and Management of Urologic Cancer. 2nd ed. Baltimore, Md: Williams and Wilkins, 1983, pp 581-597.
-
Schellhammer PF, Spaulding JT: Carcinoma of the penis. In: Paulson DF, ed.: Genitourinary Surgery. Vol. 2. New York: Churchill Livingston, 1984, pp 629-654.
-
Johnson DE, Lo RK: Tumors of the penis, urethra, and scrotum. In: deKernion JB, Paulson DF, eds.: Genitourinary Cancer Management. Philadelphia, Pa: Lea and Febiger, 1987, pp 219-258.
-
McLean M, Akl AM, Warde P, et al.: The results of primary radiation therapy in the management of squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 25 (4): 623-8, 1993.
[PUBMED Abstract]
-
Crook JM, Jezioranski J, Grimard L, et al.: Penile brachytherapy: results for 49 patients. Int J Radiat Oncol Biol Phys 62 (2): 460-7, 2005.
[PUBMED Abstract]
-
Horenblas S, van Tinteren H, Delemarre JF, et al.: Squamous cell carcinoma of the penis. II. Treatment of the primary tumor. J Urol 147 (6): 1533-8, 1992.
[PUBMED Abstract]
-
Theodorescu D, Russo P, Zhang ZF, et al.: Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J Urol 155 (5): 1626-31, 1996.
[PUBMED Abstract]
-
Lindegaard JC, Nielsen OS, Lundbeck FA, et al.: A retrospective analysis of 82 cases of cancer of the penis. Br J Urol 77 (6): 883-90, 1996.
[PUBMED Abstract]
-
Ornellas AA, Seixas AL, Marota A, et al.: Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 151 (5): 1244-9, 1994.
[PUBMED Abstract]
-
Young MJ, Reda DJ, Waters WB: Penile carcinoma: a twenty-five-year experience. Urology 38 (6): 529-32, 1991.
[PUBMED Abstract]
-
Perdonà S, Autorino R, De Sio M, et al.: Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study. Urology 66 (6): 1282-6, 2005.
[PUBMED Abstract]
Back to Top
< Previous Section | Next Section > |